Skip to main content
SpringerLink
Log in

Preparation and Evaluation of Extended-Release Nanofibers Loaded with Pramipexole as a Novel Oral Drug Delivery System: Hybridization of Hydrophilic and Hydrophobic Polymers

  • Original Article
  • Published:
Journal of Pharmaceutical Innovation Aims and scope Submit manuscript

Abstract

Purpose

Pramipexole (Prami) is renowned as one of the most widely used drugs in the treatment of Parkinson’s disease. This study aimed to prepare slow-release nanofibers of Prami to reduce (or control) the release rate of the drug from the formulation.

Methods

For this purpose, polyvinyl alcohol (PVA)/carboxymethylcellulose (CMC) nanofibers loaded with Prami were fabricated using the electrospinning technique and characterized using scanning electron microscopy (SEM) and infrared spectroscopy (FTIR). A test has been conducted to evaluate the swelling of the formulations and an HPLC method has been used to assess the effect of both co-electrospinning with polycaprolactone (PCL) nanofibers and cross-linking using glutaraldehyde (GA) vapors on the release kinetics.

Results

The results showed that the co-electrospun nanofibers cross-linked by 12-h exposure to GA vapor exhibited slow release compared to non-hybrid and non-cross-linked fibers. The cell viability assay using the MTT test showed that the nanofibers were cytocompatibility regarding SFIF-PI 44 cell line. The hybrid cross-linked nanofibers were placed in the gelatin shell capsule, and the dissolution profile of the drug in the capsules was investigated.

Conclusions

These results indicated that using nanofibers as the carrier encapsulated in the conventional capsule dosage form can be considered as a new formulation to reduce the used excipients and ease of production.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. De Rijk MC, Rocca W, Anderson D, Melcon M, Breteler M, Maraganore D. A population perspective on diagnostic criteria for Parkinson’s disease. Neurology. 1997;48(5):1277–81.

    Article  PubMed  Google Scholar 

  2. Balestrino R, Schapira AHV. Parkinson disease. Eur J Neurol. 2020;27(1):27–42.

    Article  CAS  PubMed  Google Scholar 

  3. Kreiss DS, Bergstrom DA, Gonzalez AM, Huang K-X, Sibley DR, Walters JR. Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities. Eur J Pharmacol. 1995;277(2–3):209–14.

    Article  CAS  PubMed  Google Scholar 

  4. Weiner W, Factor S, Jankovic J, Hauser R, Tetrud J, Waters C, et al. The long-term safety and efficacy of pramipexole in advanced Parkinson’s disease. Parkinsonism Relat Disord. 2001;7(2):115–20.

    Article  PubMed  Google Scholar 

  5. Möller JC, Oertel WH, Köster J, Pezzoli G, Provinciali L. Long-term efficacy and safety of pramipexole in advanced Parkinson’s disease: results from a European multicenter trial. Movement disorders: official journal of the Movement Disorder Society. 2005;20(5):602–10.

    Article  PubMed  Google Scholar 

  6. Danzeisen R, Schwalenstoecker B, Gillardon F, Buerger E, Krzykalla V, Klinder K, et al. Targeted antioxidative and neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x [(+) 2-amino-4, 5, 6, 7-tetrahydro-6-Lpropylamino-benzathiazole dihydrochloride]. J Pharmacol Exp Ther. 2006;316(1):189–99.

    Article  CAS  PubMed  Google Scholar 

  7. Kitamura Y, Kosaka T, Kakimura J-I, Matsuoka Y, Kohno Y, Nomura Y, et al. Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells. Mol Pharmacol. 1998;54(6):1046–54.

    Article  CAS  PubMed  Google Scholar 

  8. Gu M, Irvani M, Cooper JM, King D, Jenner P, Schapira AH. Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms. J Neurochem. 2004;91(5):1075–81.

    Article  CAS  PubMed  Google Scholar 

  9. Abramova NA, Cassarino DS, Khan SM, Painter TW, Bennett JP Jr. Inhibition by R (+) or S (–) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma. J Neurosci Res. 2002;67(4):494–500.

    Article  PubMed  Google Scholar 

  10. Ferrari-Toninelli G, Maccarinelli G, Uberti D, Buerger E, Memo M. Mitochondria-targeted antioxidant effects of S (-) and R (+) pramipexole. BMC Pharmacol. 2010;10(1):1–6.

    Article  Google Scholar 

  11. Vlachou M, Kikionis S, Siamidi A, Tragou K, Kapoti S, Ioannou E, et al. Fabrication and characterization of electrospun nanofibers for the modified release of the chronobiotic hormone melatonin. Curr Drug Deliv. 2019;16(1):79–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Agarwal S, Wendorff JH, Greiner A. Use of electrospinning technique for biomedical applications. Polymer. 2008;49(26):5603–21.

    Article  CAS  Google Scholar 

  13. Chakraborty S, Liao I-C, Adler A, Leong KW. Electrohydrodynamics: a facile technique to fabricate drug delivery systems. Adv Drug Deliv Rev. 2009;61(12):1043–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ramakrishna S, Fujihara K, Teo W-E, Yong T, Ma Z, Ramaseshan R. Electrospun nanofibers: solving global issues. Mater Today. 2006;9(3):40–50.

    Article  CAS  Google Scholar 

  15. El-Newehy MH, El-Naggar ME, Alotaiby S, El-Hamshary H, Moydeen M, Al-Deyab S. Preparation of biocompatible system based on electrospun CMC/PVA nanofibers as controlled release carrier of diclofenac sodium. J Macromol Sci A. 2016;53(9):566–73.

    Article  CAS  Google Scholar 

  16. Joseph BKSV, Sabu C, Kalarikkal N, Thomas S. Cellulose nanocomposites: fabrication and biomedical applications. J Bioresour Bioproduct. 2020;5(4):223–37.

  17. Santos C, Silva CJ, Büttel Z, Guimarães R, Pereira SB, Tamagnini P, et al. Preparation and characterization of polysaccharides/PVA blend nanofibrous membranes by electrospinning method. Carbohydr Polym. 2014;99:584–92.

    Article  CAS  PubMed  Google Scholar 

  18. Shao D, Jiang Z, Wang X, Li J, Meng Y. Plasma induced grafting carboxymethyl cellulose on multiwalled carbon nanotubes for the removal of UO22+ from aqueous solution. J Phys Chem B. 2009;113(4):860–4.

    Article  CAS  PubMed  Google Scholar 

  19. Islam MS, Karim MR. Fabrication and characterization of poly (vinyl alcohol)/alginate blend nanofibers by electrospinning method. Colloids Surf A Physicochem Eng Asp. 2010;366(1–3):135–40.

    Article  CAS  Google Scholar 

  20. Kapahi H, Khan NM, Bhardwaj A, Mishra N. Implication of nanofibers in oral drug delivery. Curr Pharm Des. 2015;21(15):2021–36.

    Article  CAS  PubMed  Google Scholar 

  21. Wilding IR. Site-specific drug delivery in the gastrointestinal tract. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2000;17(6).

  22. Cole ET, Scott RA, Connor AL, Wilding IR, Petereit H-U, Schminke C, et al. Enteric coated HPMC capsules designed to achieve intestinal targeting. Int J Pharm. 2002;231(1):83–95.

    Article  CAS  PubMed  Google Scholar 

  23. Tort S, Han D, Steckl AJ. Self-inflating floating nanofiber membranes for controlled drug delivery. Int J Pharm. 2020;579:119164.

  24. Rostami E, Kashanian S, Azandaryani AH. Preparation of solid lipid nanoparticles as drug carriers for levothyroxine sodium with in vitro drug delivery kinetic characterization. Mol Biol Rep. 2014;41(5):3521–7.

    Article  CAS  PubMed  Google Scholar 

  25. Alipour R, Khorshidi A, Shojaei AF, Mashayekhi F, Moghaddam MJM. Silver sulfadiazine-loaded PVA/CMC nanofibers for the treatment of wounds caused by excision. Fibers Polym. 2019;20(12):2461–9.

    Article  CAS  Google Scholar 

  26. Allafchian A, Hosseini H, Ghoreishi SM. Electrospinning of PVA-carboxymethyl cellulose nanofibers for flufenamic acid drug delivery. Int J Biol Macromol. 2020;163:1780–6.

    Article  CAS  PubMed  Google Scholar 

  27. Venkateswarlu K, Thakur H, Babu TNB. Fabrication of extended release tablets of pramipexole: in-vitro studies. Pharm Methods. 2017;8(2).

  28. Darbasizadeh B, Fatahi Y, Feyzi-Barnaji B, Arabi M, Motasadizadeh H, Farhadnejad H, et al. Crosslinked-polyvinyl alcohol-carboxymethyl cellulose/ZnO nanocomposite fibrous mats containing erythromycin (PVA-CMC/ZnO-EM): fabrication, characterization and in-vitro release and anti-bacterial properties. Int J Biol Macromol. 2019;141:1137–46.

    Article  CAS  PubMed  Google Scholar 

  29. Hashmi M, Ullah S, Ullah A, Saito Y, Haider M, Bie X, et al. Carboxymethyl cellulose (CMC) based electrospun composite nanofiber mats for food packaging. Polymers. 2021;13(2):302.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67(3):217–23.

    CAS  PubMed  Google Scholar 

  31. Singhvi G, Singh M. Review: in vitro drug release characterization models. Int J Pharm Sci Res. 2011;2:77–84.

    Google Scholar 

  32. Fredenberg S, Wahlgren M, Reslow M, Axelsson A. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems–a review. Int J Pharm. 2011;415(1–2):34–52.

    Article  CAS  PubMed  Google Scholar 

  33. Liu J-Y, Zhang X-X, Huang H-Y, Lee B-J, Cui J-H, Cao Q-R. Esomeprazole magnesium enteric-coated pellet-based tablets with high acid tolerance and good compressibility. J Pharm Investig. 2018;48(3):341–50.

    Article  CAS  Google Scholar 

  34. Kuang C, Sun Y, Li B, Fan R, Zhang J, Yao Y, et al. Preparation and evaluation of duloxetine hydrochloride enteric-coated pellets with different enteric polymers. Asian J Pharm Sci. 2017;12(3):216–26.

    Article  PubMed  Google Scholar 

Download references

Funding

The authors gratefully recognize the research council of Kermanshah University of Medical Sciences [Grant Number: 4000226] for financial support.

Author information

Authors and Affiliations

  1. Nano Drug Delivery Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran

    Mazdak Limoee, Hadi Samadian, Zahra Pourmanouchehri & Leila Behbood

  2. Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran

    Mohammad Allahdad & Amirhossein Vosoughi

  3. Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran

    Gholamreza Bahrami, Zahra Pourmanouchehri, Leila Hosseinzadeh & Leila Behbood

  4. Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran

    Bahareh Mohammadi & Kimia Forouhar

Authors
  1. Mazdak Limoee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohammad Allahdad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hadi Samadian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gholamreza Bahrami
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zahra Pourmanouchehri
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Leila Hosseinzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bahareh Mohammadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Amirhossein Vosoughi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kimia Forouhar
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Leila Behbood
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leila Behbood.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Limoee, M., Allahdad, M., Samadian, H. et al. Preparation and Evaluation of Extended-Release Nanofibers Loaded with Pramipexole as a Novel Oral Drug Delivery System: Hybridization of Hydrophilic and Hydrophobic Polymers. J Pharm Innov 18, 287–299 (2023). https://doi.org/10.1007/s12247-022-09625-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12247-022-09625-1

Keywords

Search

Navigation